For the early detection of hepatocellular cancer, core fucosylation of alpha‐fetoprotein is an approved biomarker, differentiating hepatocellular carcinoma from cirrhosis and chronic hepatitis, thus improving the specificity of alpha‐fetoprotein as a biomarker.9, 10. This evidence concerns the gene AFP and chronic hepatitis.